胎儿镜气管球囊封堵术治疗重度先天性膈疝的单中心结局
该前瞻性队列研究纳入14例重度先天性膈疝胎儿,在孕26 0/7-29 6/7周行胎儿镜气管球囊封堵术,4-6周后移除球囊。术后观察/预期肺头比中位数从23.2%升至62.8%,移除后降至46.6%(P<.003)。新生儿存活率93%,出院存活率86%,产科并发症少。
要点
- 胎儿镜气管球囊封堵术在重度先天性膈疝中技术可行,所有病例均成功置入并维持球囊。
- 术后肺头比显著增加,球囊移除后有所下降,但仍高于术前。
- 新生儿存活率93%,出院存活率86%,但多数需高频通气和ECMO支持。
核心结论
- 胎儿镜气管球囊封堵术治疗重度先天性膈疝在本单中心可行,产科并发症少,婴儿结局良好。
研究设计与样本
- 前瞻性队列研究,筛查57例孕妇,纳入14例(25%),研究时间为2015至2019年。
- 纳入标准为先天性膈疝且观察/预期肺头比小于30%,在孕26 0/7-29 6/7周行胎儿镜气管球囊封堵术,4-6周后移除球囊。
主要发现
- 12例(86%)为左侧膈疝,术前观察/预期肺头比中位数23.2%(范围15.8-29.0%)。
- 封堵成功率为100%,球囊中位留置34天(范围17-44天),移除时中位孕周33 4/7周(范围32 1/7-34 4/7)。
- 术后观察/预期肺头比中位数升至62.8%(范围44.0-108),移除后降至46.6%(范围30-92),差异均有统计学意义(P<.003)。
- 所有患者使用阴道黄体酮预防早产,11例(79%)需额外宫缩抑制剂,3例(21%)放置阴道托,5例(36%)因羊水过多行羊水减量。
- 中位分娩孕周39 2/7周(范围33 6/7-39 4/7),足月产8例(57%);12例(86%)新生儿需高频通气,7例(50%)需ECMO中位7天(范围3-19天),所有新生儿均需补片修补。
临床怎么用
- 对于重度先天性膈疝且观察/预期肺头比小于30%的胎儿,可考虑在本中心开展胎儿镜气管球囊封堵术。
- 术后需密切监测早产风险,使用黄体酮并必要时加用宫缩抑制剂、阴道托或羊水减量。
- 新生儿出生后常需高频通气、ECMO和补片修补,应做好相应围产期管理准备。
局限性
- 单中心研究,样本量小(14例),筛查至纳入比例仅25%。
- 无对照组,结果需进一步多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess feasibility and maternal and infant outcome after fetoscopic tracheal balloon occlusion in patients with severe congenital diaphragmatic hernia. METHODS: We conducted a prospective cohort study of fetuses with congenital diaphragmatic hernia and observed/expected lung/head ratio less than 30%. Eligible women had planned fetoscopic tracheal balloon occlusion at 26 0/7-29 6/7 weeks of gestation and balloon removal 4-6 weeks later. Standardized prenatal and postnatal care was at a single institution. Fetoscopic tracheal balloon occlusion details, lung growth, obstetric complications, birth outcome, and infant outcome details until discharge were evaluated. RESULTS: Of 57 women screened, 14 (25%) were enrolled between 2015 and 2019. The congenital diaphragmatic hernia was left in 12 (86%); the pre-fetoscopic tracheal balloon occlusion observed/expected lung/head ratio was 23.2% (range 15.8-29.0%). At a median gestational age of 28 5/7 weeks (range 27 3/7-29 6/7), fetoscopic tracheal balloon occlusion was successful in all cases, and balloons remained in situ. Removal was elective in 10 (71%) patients, by ultrasound-guided needle puncture in eight (57%), and occurred at a median of 33 4/7 weeks of gestation (range 32 1/7-34 4/7; median occlusion 34 days, range 17-44). The post-fetoscopic tracheal balloon occlusion observed/expected lung/head ratio increased to a median of 62.8% (44.0-108) and fell to a median of 46.6% (range 30-92) after balloon removal (all Mann Whitney U, P<.003). For prevention of preterm birth, all patients received vaginal progesterone; 11 (79%) required additional tocolytics, three (21%) had vaginal pessary placement for cervical shortening, and five (36%) had amnioreduction for polyhydramnios. Median gestational age at birth was 39 2/7 weeks (range 33 6/7-39 4/7), with term birth in eight (57%) patients. Twelve (86%) neonates required high-frequency ventilation, and seven (50%) required extracorporeal membrane oxygenation for a median of 7 days (range 3-19). All neonates needed patch repair. Neonatal survival was 93% (n=13, 95% CI 49-100%), and survival to hospital discharge was 86% (n=12, 95% CI 44-100%). CONCLUSION: Fetoscopic tracheal balloon occlusion for severe congenital diaphragmatic hernia was feasible in our single-center setting, with few obstetric complications and favorable infant outcome. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02710968.
引用
- Baschat AA, Rosner M, Millard SE, et al. Single-Center Outcome of Fetoscopic Tracheal Balloon Occlusion for Severe Congenital Diaphragmatic Hernia. Obstet Gynecol. 2020. PMID: 32028493. doi:10.1097/AOG.0000000000003692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。